AVM Biotechnology

    OverviewSuggest Edit

    AVM Biotechnology is a company dedicated to the discovery, development, and commercialization of stem cell-enabling technologies for regenerative medicine, immuno-oncology, and fully human biologics applications. Its lead molecule aims to replace toxic chemotherapy with a non-toxic alternative in cancer patients receiving immunotherapy and for patients undergoing allogeneic bone marrow transplant.
    TypePrivate
    Founded2008
    Websiteavmbiotech.com

    Latest Updates

    Employees (est.) (Mar 2020)17

    AVM Biotechnology Financials and Metrics

    Summary Metrics

    Founding Date

    2008

    AVM Biotechnology latest funding size

    $2.84 m
    Show all financial metrics

    AVM Biotechnology Online and Social Media Presence

    Embed Graph

    AVM Biotechnology Frequently Asked Questions

    • When was AVM Biotechnology founded?

      AVM Biotechnology was founded in 2008.

    • How many employees does AVM Biotechnology have?

      AVM Biotechnology has 17 employees.

    • Who are AVM Biotechnology competitors?

      Competitors of AVM Biotechnology include NeuBase Therapeutics, Genprex and Ablynx.